PerkinElmer to acquire Horizon Discovery for $383m 02-Nov-2020 By Rachel Arthur PerkinElmer will acquire UK cell engineering company Horizon Discovery, expanding its portfolio with gene editing and gene modulation tools.
NEWS IN BRIEF Glenmark opts for Horizon’s gene edited cell lines 01-Oct-2019 By Ben Hargreaves Glenmark signs a full commercial license to utilize Horizon’s gene edited CHO cell lines to be added to the former’s biomanufacturing process.